PRQR
ProQR Therapeutics N.V. SEC filings
Every EDGAR filing for ProQR Therapeutics N.V. (PRQR), newest first, with AI summaries and stories.
- Ticker
- PRQR
- CIK
- 1612940
- Latest filing
- Sep 23
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE4ProQR Therapeutics N.V.PRQRLIVE Boer Daniel Anton de, insider filing for PRQR
Boer Daniel Anton de, reporting
NOTABLESCHEDULE 13D/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by VAN HERK INVESTMENTS B.V. (amended)
VAN HERK INVESTMENTS B.V., filed by
ROUTINESCHEDULE 13GProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by Aberdeen Group plc
Aberdeen Group plc, filed by
ROUTINESCHEDULE 13G/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by ELI LILLY & Co (amended)
ELI LILLY & Co, filed by
ROUTINE4ProQR Therapeutics N.V.PRQRLIVE Bart Filius, insider filing for PRQR
Bart Filius, reporting
ROUTINEEFFECTProQR Therapeutics N.V.PRQRLIVE ROUTINE424B5ProQR Therapeutics N.V.PRQRLIVE ROUTINESCHEDULE 13G/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by Privium Fund Management B.V. (amended)
Privium Fund Management B.V., filed by
ROUTINE4ProQR Therapeutics N.V.PRQRLIVE Boer Daniel Anton de, insider filing for PRQR
Boer Daniel Anton de, reporting
ROUTINE4ProQR Therapeutics N.V.PRQRLIVE Boer Daniel Anton de, insider filing for PRQR
Boer Daniel Anton de, reporting
ROUTINEF-3ProQR Therapeutics N.V.PRQRLIVE NOTABLESCHEDULE 13D/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by VAN HERK INVESTMENTS B.V. (amended)
VAN HERK INVESTMENTS B.V., filed by
ROUTINE4/AProQR Therapeutics N.V.PRQRLIVE 2 insider filings
Gylvin Lykke Hinsch, insider filing for PRQR (amended)
Show all 2
- 4/AInsider filing for PRQR (amended)
- 4Insider filing for PRQR
Gylvin Lykke Hinsch, reporting
ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE424B5ProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE NOTABLESCHEDULE 13D/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by VAN HERK INVESTMENTS B.V. (amended)
VAN HERK INVESTMENTS B.V., filed by
ROUTINE4ProQR Therapeutics N.V.PRQRLIVE Gylvin Lykke Hinsch, insider filing for PRQR
Gylvin Lykke Hinsch, reporting
ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE3ProQR Therapeutics N.V.PRQRLIVE Gylvin Lykke Hinsch, new insider at PRQR
Gylvin Lykke Hinsch, reporting
ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE3ProQR Therapeutics N.V.PRQRLIVE 10 insider filings
Domenico Valerio, new insider at PRQR
Show all 10
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
- 3New insider at PRQR
Domenico Valerio, reporting
NOTABLE20-FProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE NOTABLESCHEDULE 13D/AProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by VAN HERK INVESTMENTS B.V. (amended)
VAN HERK INVESTMENTS B.V., filed by
ROUTINESCHEDULE 13GProQR Therapeutics N.V.PRQRLIVE Ownership stake disclosure by Privium Fund Management B.V.
Privium Fund Management B.V., filed by
ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.PRQRLIVE ROUTINE6-KProQR Therapeutics N.V.LIVE